Pathogenic signaling in multiple myeloma
Author:
Funder
NCI
Council for Chemical Research
National Institutes of Health
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference144 articles.
1. Pathogenic B-cell receptor signaling in lymphoid malignancies: new insights to improve treatment;Young;Immunol Rev,2019
2. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients;Kumar;Leukemia,2014
3. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells;Obeng;Blood,2006
4. Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study;Qin;Blood Adv,2019
5. IRF4 addiction in multiple myeloma;Shaffer;Nature,2008
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of biomarkers in multiple myeloma: A comprehensive study combining microarray analysis and Mendelian randomization;Journal of Cellular and Molecular Medicine;2024-06
2. β-adrenergic modulation of IL-6/gp130 and SOCS-1 in multiple myeloma: therapeutic strategy for stress induced-inflammatory response;memo - Magazine of European Medical Oncology;2024-02-09
3. Anti-Angiogenic Effect of Bortezomib Treatment in Multiple Myeloma is Associated with Lower NF-KB and OPN Expression;J BIOL REG HOMEOS AG;2023
4. Coexistence of myeloproliferative neoplasms with multiple myeloma;Cancer Pathogenesis and Therapy;2023-12
5. Cytokine receptor IL27RA is an NF-κB–responsive gene involved in CD38 upregulation in multiple myeloma;Blood Advances;2023-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3